<DOC>
	<DOCNO>NCT01092299</DOCNO>
	<brief_summary>Part 1 : The purpose study determine pharmacokinetic profile 4 different Extended/modified-release formulation one immediate release formulation AZD1446 . In addition food effect AZD1446 pharmacokinetics investigate . Part 2 : To asses safety tolerability select formulation ( ) part 1 elderly healthy volunteer .</brief_summary>
	<brief_title>A Bioavailability Study Comparing Modified-release Capsules Immediate Release Capsules Fed Fasting Conditions</brief_title>
	<detailed_description />
	<criteria>Body mass index ( BMI ) 19 30 kg/m2 Clinically normal finding physical examination History clinically significant disease disorder History presence gastrointestinal , hepatic renal disease condition know interfere absorption , distribution , metabolism excretion drug History present symptom sign severe allergy/hypersensitivity reaction include severe food allergy , judge investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Phase I</keyword>
	<keyword>Relative bioavailability</keyword>
	<keyword>Pharmacokinetic study</keyword>
	<keyword>AZD1446</keyword>
	<keyword>healthy volunteer</keyword>
</DOC>